← Insider buys
XGN

Exagen Inc. · Healthcare

President and CEO John Aballi sold $270K of Exagen Inc.

Sold$269,791
$7.87Price
34,294Shares
−4%Stake

What XGN did after the filing

Filed Oct 19Copier in Oct 20
The stock from Tue, Oct 20 open, $7.56
−3.8%
S&P 500, same days
−0.8%

3 of 30 trading days so far, to the Oct 23 close.

Traded Fri, Oct 16. Filed Mon, Oct 19, 4:52 PM ET, after the close. Returns use the Oct 20 open and the Oct 23 close. Not investment advice.